Literature DB >> 8943381

Breaking of B cell tolerance toward a highly conserved self protein.

I Dalum1, M R Jensen, P Hindersson, H I Elsner, S Mouritsen.   

Abstract

Self proteins are processed and presented by APCs in the same way as foreign proteins. Presentation of fragments derived from self proteins does not, however, lead to Th cell stimulation because of T cell tolerance. In this study, a novel approach was used to investigate whether B cell tolerance toward a self Ag could be due to the absence of this Th cell recognition. The highly conserved nonimmunogenic protein ubiquitin was used as a model protein. Two modified ubiquitin molecules were constructed with ubiquitin segments exchanged either with the T cell epitope, OVA(325-336), which binds to the mouse A(d) MHC class II molecule, or with the T cell epitope, hen egg lysozyme(50-61), which binds to the A(k) molecule. Mice were immunized with the resulting proteins. Both modified proteins elicited strong autoantibody responses toward soluble native ubiquitin, demonstrating that insertion of a single foreign T cell epitope can overcome the B cell nonresponsiveness. The T cell regulatory role of one of the inserted foreign T cell epitopes in ubiquitin was studied, and at least two different Th cell specificities were found to operate in the response. The T cells were directed against: 1) the inserted epitope, and 2) a combination of the inserted epitope and parts of the neighboring ubiquitin regions. Therefore, the absence of T cell help seems to be an important reason for B cell tolerance toward self proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943381

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  B-cell repertoire specific for an unfolded self-determinant of mouse lysozyme escape tolerance and dominantly participate in the autoantibody response.

Authors:  Yoshiyuki Tsujihata; Yousuke Mizukami; Tadashi Ueda; Takanori So; Taiji Imoto
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.

Authors:  M Richard; R K Grencis; N E Humphreys; J C Renauld; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines.

Authors:  D Zagury; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Authors:  S Phogat; R T Wyatt; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

5.  T-cell recognition of lipid peroxidation products breaks tolerance to self proteins.

Authors:  D M Wuttge; M Bruzelius; S Stemme
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

6.  Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.

Authors:  B Chackerian; D R Lowy; J T Schiller
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.

Authors:  Catherine Uyttenhove; Reece G Marillier; Fabienne Tacchini-Cottier; Mélanie Charmoy; Rachel R Caspi; Jesse M Damsker; Stanislas Goriely; Dan Su; Jo Van Damme; Sofie Struyf; Ghislain Opdenakker; Jacques Van Snick
Journal:  J Leukoc Biol       Date:  2011-03-08       Impact factor: 4.962

8.  DNA vaccination targeting macrophage migration inhibitory factor prevents murine experimental colitis.

Authors:  T Ohkawara; Y Koyama; S Onodera; H Takeda; M Kato; M Asaka; J Nishihira
Journal:  Clin Exp Immunol       Date:  2010-11-09       Impact factor: 4.330

9.  Recombinatorial cloning using heterologous lox sites.

Authors:  Robert W Siegel; Nileena Velappan; Peter Pavlik; Leslie Chasteen; Andrew Bradbury
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

Review 10.  Immunogenicity of Protein Pharmaceuticals.

Authors:  Robert Dingman; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-12-30       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.